SK Biopharmaceuticals turns to black in Q4
SEOUL, SK Biopharmaceuticals Co. on Monday reported its fourth-quarter net profit of 7.8 billion won (US$5.8 million), turning from a loss of 43.9 billion won a year earlier.
Operating income for the October-December period was 15.2 billion, compare…